Skip to content
Trial Eligibility
Menu

Migraine Clinical Trials near Bethesda, MD

17 studies for Migraine are recruiting at 18 sites within 50 miles of Bethesda, Maryland, according to ClinicalTrials.gov data processed .

Distances are city-level approximations. See all Migraine trials in the US or all trials near Bethesda.

Your ZIP is looked up in your browser. We don't receive or store it.

Recruiting now

Migraine studies enrolling near Bethesda

Showing 17 studies, nearest first.
  1. NIMH Rhythms and Blues Study: A Prospective Natural History Study of Motor Activity, Mood States, and Bipolar Disorder

    NCT05669703

    • Observational
    • Ages 8 to 70 years
    • Sex: All
    • Accepts healthy volunteers

    Nearest site: National Institutes of Health Clinical Center (Bethesda, MD)

    Distance to nearest recruiting site
    <1 mi (city-level)
    Recruiting sites
    1 site within 50 mi
  2. Efficacy of Xeomin for Migraines in Patients With Traumatic Brain Injuries vs. Anomalous Health Incidents

    NCT07267819

    • Observational
    • Ages 18 years and older
    • Sex: All

    Nearest site: National Intrepid Center of Excellence (NICOE) (Bethesda, MD)

    Distance to nearest recruiting site
    <1 mi (city-level)
    Recruiting sites
    1 site within 50 mi
  3. A Study to Learn About the Study Medicine Called Rimegepant in Women When Used for Intermittent Prevention of Menstrual Migraine

    NCT06641466

    • Phase 3
    • Ages 18 to 45 years
    • Sex: Female

    Nearest site: MedStar Health Neurology/MedStar Georgetown Headache Center (McLean, VA)

    Distance to nearest recruiting site
    ~5 mi (city-level)
    Recruiting sites
    1 site within 50 mi
  4. Rimegepant as Preemptive Treatment for Predictable Trigger-Induced Migraine in Adult Patients in the US

    NCT07301008

    • Phase 4
    • Ages 18 years and older
    • Sex: All

    Nearest site: MedStar Health: Neurology at McLean (McLean, VA)

    Distance to nearest recruiting site
    ~5 mi (city-level)
    Recruiting sites
    1 site within 50 mi
  5. A Study to Learn About the Safety of Taking an Additional Dose of the Medicine Rimegepant in Adults With Migraine

    NCT07609914

    • Phase 4
    • Ages 18 years and older
    • Sex: All

    Nearest site: Medstar Health - Department of Neurology (McLean, VA)

    Distance to nearest recruiting site
    ~5 mi (city-level)
    Recruiting sites
    1 site within 50 mi
  6. Study of EVO756 in Adults With Migraine

    NCT07616128

    • Phase 2
    • Ages 18 to 64 years
    • Sex: All

    Nearest site: MedStar Health: Headache Center at McLean (McLean, VA)

    Distance to nearest recruiting site
    ~5 mi (city-level)
    Recruiting sites
    1 site within 50 mi
  7. Study to Assess Adverse Events and Disease Activity of Oral Ubrogepant Tablets for the Acute Treatment of Migraine in Children and Adolescents (Ages 6-17)

    NCT05125302

    • Phase 3
    • Ages 6 to 17 years
    • Sex: All

    Nearest sites: Emerson Clinical Research Institute - Connecticut Avenue - Washington /ID# 231693 (Washington D.C., DC); Pharmasite Research, Inc. /ID# 227908 (Baltimore, MD)

    Distance to nearest recruiting site
    ~7 mi (city-level)
    Recruiting sites
    2 sites within 50 mi
  8. Randomized Study in Children and Adolescents With Migraine: Acute Treatment

    NCT04649242

    • Phase 3
    • Ages 6 to 17 years
    • Sex: All

    Nearest site: Children's National Medical Center (Washington D.C., DC)

    Distance to nearest recruiting site
    ~7 mi (city-level)
    Recruiting sites
    1 site within 50 mi
  9. Long-term Safety Study of Rimegepant in Pediatric Subjects for the Acute Treatment of Migraine

    NCT04743141

    • Phase 3
    • Ages 6 to 17 years
    • Sex: All

    Nearest site: Children's National Medical Center (Washington D.C., DC)

    Distance to nearest recruiting site
    ~7 mi (city-level)
    Recruiting sites
    1 site within 50 mi
  10. Efficacy and Safety Study of Rimegepant for the Preventative Treatment of Migraine in Pediatric Subjects

    NCT05156398

    • Phase 3
    • Ages 6 to 17 years
    • Sex: All

    Nearest site: Velocity Clinical Research, Washington DC (Washington D.C., DC)

    Distance to nearest recruiting site
    ~7 mi (city-level)
    Recruiting sites
    1 site within 50 mi
  11. A Study to Learn About the Study Medicine Called Zavegepant (PF-07930207) in Children With a History of Migraine

    NCT06995729

    • Phase 1
    • Ages 6 to 11 years
    • Sex: All

    Nearest site: Velocity Clinical Research, Washington DC (Washington D.C., DC)

    Distance to nearest recruiting site
    ~7 mi (city-level)
    Recruiting sites
    1 site within 50 mi
  12. A Pivotal Clinical Study to Evaluate the MySalvia System for the Treatment of Resistant Migraine

    NCT07719608

    • Interventional
    • Ages 22 to 84 years
    • Sex: All

    Nearest site: MedStar Health Research Institute (Olney, MD)

    Distance to nearest recruiting site
    ~12 mi (city-level)
    Recruiting sites
    1 site within 50 mi
  13. A Study With Eptinezumab in Children and Adolescents (6 to 17 Years) With Chronic or Episodic Migraine

    NCT05164172

    • Phase 3
    • Ages 6 to 17 years
    • Sex: All

    Nearest site: University of Maryland School of Medicine (Baltimore, MD)

    Distance to nearest recruiting site
    ~34 mi (city-level)
    Recruiting sites
    1 site within 50 mi
  14. Pivotal Study of N-acetyl-L-leucine for CACNA1A

    NCT07221292

    • Phase 3
    • Ages 4 years and older
    • Sex: All

    Nearest site: Johns Hopkins University (Baltimore, MD)

    Distance to nearest recruiting site
    ~34 mi (city-level)
    Recruiting sites
    1 site within 50 mi
  15. Bilateral Embolization of the Middle Meningeal Arteries for Refractory Chronic Migraine

    NCT07223008

    • Interventional
    • Ages 18 to 80 years
    • Sex: All

    Nearest site: Johns Hopkins Medicine (Baltimore, MD)

    Distance to nearest recruiting site
    ~34 mi (city-level)
    Recruiting sites
    1 site within 50 mi
  16. A Study to Evaluate the Efficacy and Safety of Elismetrep (K-304) in the Acute Treatment of Migraine

    NCT07645924

    • Phase 3
    • Ages 18 to 75 years
    • Sex: All

    Nearest site: Headlands Research - PharmaSite (Pikesville, MD)

    Distance to nearest recruiting site
    ~34 mi (city-level)
    Recruiting sites
    1 site within 50 mi
  17. A Long-Term Safety Study of Elismetrep (K-304) in the Acute Treatment of Migraine

    NCT07674654

    • Phase 3
    • Ages 18 years and older
    • Sex: All

    Nearest site: Headlands Research - PharmaSite (Pikesville, MD)

    Distance to nearest recruiting site
    ~34 mi (city-level)
    Recruiting sites
    1 site within 50 mi

FAQ

Common questions

What is a clinical trial?
A clinical trial is a research study in people that tests a medical, surgical or behavioral intervention, such as an investigational drug or device. Observational studies are also listed: they collect information without assigning a treatment. Read how clinical trials work.
Is there compensation for joining a Migraine clinical trial?
Compensation for time and travel may be available, but it varies by study and some studies offer none. The amount and schedule are reviewed by an ethics board and described in the consent form. See compensation in clinical trials.
How do I check if I'm eligible?
Each study lists age, sex and other inclusion and exclusion criteria on its ClinicalTrials.gov record. Only the study team can confirm eligibility, usually through a screening call or visit. Talk with your own doctor before joining any study.

Source: ClinicalTrials.gov, data processed . Recruiting US sites filtered by distance and site status; summaries shortened.